Albion Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.36K | Hold |
138
| – | – | ﹤0.01% | 440 |
|
|
2025
Q1 | $2.87K | Buy |
138
+82
| +146% | +$1.7K | ﹤0.01% | 459 |
|
|
2024
Q4 | $1.32K | Sell |
56
-477
| -89% | -$11.2K | ﹤0.01% | 590 |
|
|
2024
Q3 | $13.6K | Hold |
533
| – | – | ﹤0.01% | 315 |
|
|
2024
Q2 | $12.5K | Hold |
533
| – | – | ﹤0.01% | 316 |
|
|
2024
Q1 | $15.3K | Hold |
533
| – | – | ﹤0.01% | 294 |
|
|
2023
Q4 | $17.5K | Hold |
533
| – | – | ﹤0.01% | 279 |
|
|
2023
Q3 | $14.9K | Hold |
533
| – | – | ﹤0.01% | 274 |
|
|
2023
Q2 | $18.2K | Hold |
533
| – | – | ﹤0.01% | 276 |
|
|
2023
Q1 | $16K | Hold |
533
| – | – | ﹤0.01% | 276 |
|
|
2022
Q4 | $15K | Hold |
533
| – | – | ﹤0.01% | 273 |
|
|
2022
Q3 | $18K | Hold |
533
| – | – | ﹤0.01% | 264 |
|
|
2022
Q2 | $17K | Hold |
533
| – | – | ﹤0.01% | 280 |
|
|
2022
Q1 | $24K | Buy |
533
+11
| +2% | +$495 | ﹤0.01% | 300 |
|
|
2021
Q4 | $32K | Buy |
522
+41
| +9% | +$2.51K | ﹤0.01% | 315 |
|
|
2021
Q3 | $36K | Sell |
481
-19
| -4% | -$1.42K | ﹤0.01% | 277 |
|
|
2021
Q2 | $46K | Buy |
+500
| New | +$46K | ﹤0.01% | 260 |
|
|
2020
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 485 |
|